Choose a blog

Quintiles will help bring COPD drug to U.K. market

Quintiles will help Barcelona-based Almirall bring its new respiratory drugs to market in the United Kingdom.

Under the long-term partnership announced Monday morning, the first drug will treat chronic obstructive pulmonary disease treatment (COPD). The treatment was approved by the European Commission in late May.

Quintiles is a Durham-based contract research organization. It conducted part of the clinical study of the COPD treatment and also helps Almirall bring products to market in multiple European countries.

No financial terms of the deal were disclosed.

Cars View All
Find a Car
Go
Jobs View All
Find a Job
Go
Homes View All
Find a Home
Go

Want to post a comment?

In order to join the conversation, you must be a member of newsobserver.com. Click here to register or to log in.
Advertisements